Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine

Archives of General Psychiatry

Volumn 69, Issue 6, 2012, Pages 572-579

  Gibbons, Robert D ^a   Hur, Kwan ^a,c   Brown, C Hendricks ^a,d   Davis, John M ^b   Mann, J John ^e,f  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c HINES VA HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^f Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO; VENLAFAXINE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ADULT DISEASE; AGED; ARTICLE; CHILD; CHILDREN DEPRESSION RATING SCALE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RELEASE; FEMALE; GERIATRIC DISORDER; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRESCHOOL CHILD; RATING SCALE; REMISSION; SCHOOL CHILD; SEX DIFFERENCE; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FLUOXETINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS;

EID: 84861617489     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.2044     Document Type: Article

References (23)

1. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260.
2. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.
3. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47-53.
4. National Institute for Clinical Excellence. Depression: Management of Depression in Primary and Secondary Care. London, England: National Institute for Clinical Excellence; 2004.
5. Mathew SJ, Charney DS. Publication bias and the efficacy of antidepressants. Am J Psychiatry. 2009;166(2):140-145.
6. Melander H, Salmonson T, Abadie E, van Zwieten-Boot B. A regulatory Apologia: a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. Eur Neuropsychopharmacol. 2008;18(9):623-627.
7. Brown CH, Wang W, Sandler I. Examining how context changes intervention impact: the use of effect sizes in multilevel mixture meta-analysis. Child Dev Perspect. 2008;2(3):198-305.
8. Lavori PW, Brown CH, Duan N, Gibbons RD, Greenhouse J. Missing data in longitudinal clinical trials, part A: design and conceptual issues. Psychiatr Ann. 2008; 38(12):784-792.
9. Siddiqui O, Hung HM, O'Neill R. MMRM vs LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. J Biopharm Stat. 2009;19 (2):227-246.
10. Hedeker D, Gibbons RD. Longitudinal Data Analysis. New York, NY: John Wiley & Sons; 2006.
11. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for AdolescentsWith Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820.
12. Hedeker D, Gibbons RD, Du Toit SHC, Patterson D. SuperMix: A Program for Mixed-Effects Regression Models. Chicago, IL: Scientific Software International; 2008.
13. Elkin I, Gibbons RD, Shea MT, Sotsky SM, Watkins JT, Pilkonis PA, Hedeker D. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995;63(5):841-847.
14. March JS. Independent Evaluator Manual: Treatment for Adolescents With Depression Study (TADS), Final Version 4.1. Durham, NC: Duke University Medical Center; 2005.
15. Muthén B, Brown HC. Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling. Stat Med. 2009; 28(27):3363-3385.
16. Malone KM, Thase ME, Mieczkowski TA, Myers JE, Stull SD, Cooper TB, Mann JJ. Fenfluramine challenge test as a predictor of outcome in major depression. Psychopharmacol Bull. 1993;29(2):155-161. (Pubitemid 23311518)
17. 1Areceptor binding potential during a major depressive episode predicts poor treatment response: preliminary data froma naturalistic study. Neuropsychopharmacology. 2006;31(8):1745-1749.
18. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47(12):1093-1099.
19. Quitkin FM, Petkova E, McGrath PJ, Taylor B, Beasley C, Stewart J, Amsterdam J, Fava M, Rosenbaum J, Reimherr F, Fawcett J, Chen Y, Klein D. When should a trial of fluoxetine for major depression be declared failed? Am J Psychiatry. 2003;160(4):734-740. (Pubitemid 41079607)
20. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683-1696.
21. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002;287(14):1840- 1847. (Pubitemid 34303629)
22. McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF. A placebo-controlled study of fluoxetine vs imipramine in the acute treatment of atypical depression. Am J Psychiatry. 2000;157(3):344-350. (Pubitemid 30145918)
23. Moreno RA, Teng CT, Almeida KM, Tavares Junior H. Hypericum perforatum vs fluoxetine in the treatment of mild to moderate depression: a randomized doubleblind trial in a Brazilian sample. Rev Bras Psiquiatr. 2006;28(1):29-32.